Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Faecal microbiota transplantation (FMT) is effective for treating recurrent Clostridioides difficile infection (1)
It is phase I, open-label, single-group feasibility trial studying Microbial Ecosystem Therapeutics 2 (MET-2) (10 oral capsules daily for 2 days, 3 capsules daily for 8 days) in 19 adult patients (analyzed) with mild to moderate C difficile infection (at least one recurrence of C difficile infection within 12 months) (1)
No recurrence of C difficile infection by day 40 (defined as fewer than three unformed bowel movements in 24 hours persisting for at least 2 days) (1)
Recurrent C difficile infection absent in 15 (79%) of 19 patients at day …